ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 51

Collagen-Based Microspheres Delivering TGF-β3 For Mesenchymal STEM CELL Differentiation: An Innovative Strategy For Cartilage Engineering

Marc Mathieu1, E Belamie2, M-N Labour2, Sylvain Vigier2, Christian Jorgensen3 and Daniele Noel4, 1INSERM U844, Montpellier, France, 2ICGM UMR 5253, MONTPELLIER, France, 3Department of therapy & Immuno-Rhumatology, Inserm U844, CHU saint-Eloi, Université Montpellier 1, CHU Lapeyronie, Montpellier, France, 4Inserm U844, UM1, Montpellier, France

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: cartilage, mesenchymal stem cells and tissue engineering

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint (Cartilage and Osteoarthritis)

Session Type: Abstract Submissions (ACR)

Background/Purpose: Because of a poor self-healing ability, joint cartilage undergoes progressive degradation in the course of aging or following traumatic injuries. One promising therapeutic approach is the use of mesenchymal stem cells (MSC), which have the potential to differentiate into chondrocytes. However, anchorage of MSC to the sites of injury and their differentiation in situ require combining cells with a biomaterial releasing a differentiation factor such as TGFβ3. Our objective was to design and test a new scaffold to support chondrogenic differentiation.

Methods:

Microspheres were formed using an acidic type I collagen solution and perfluorated oil, stabilized by a surfactant. Spherical microparticles of fibrillar collagen were obtained through a sol-gel transition induced in aqueous droplets in contact with ammonia vapors. Microspheres were impregnated with TGFβ3 and release of this factor was measured using a reporter gene assay. Impregnated microspheres were combined with human MSC and cultivated in vitro or subcutaneously injected into immunodeficient mice. Expression of chondrocyte markers was monitored by RT-qPCR and immunohistochemistry.

Results:

Microspheres are constituted by a gel of striated collagen fibrils and are 300±67 μm in diameter. Fibrils occupy ca. 5% of the total volume, forming an entangled network with pores of 1-10 μm. After MSC adhesion onto the microspheres and in vitro culture for 21 days, they differentiate into chondrocytes expressing the specific markers, such as collagen type II variant B and aggrecan. The type I collagen matrix is progressively degraded and replaced by the cartilaginous matrix. In vivo, MSC form a tissue histologically resembling cartilage which stain positive for collagen II and aggrecan.

Conclusion:

The biomaterial described here is promising for cartilage engineering. Future improvements aim at obtaining microspheres of smaller and more homogenous sizes, which will facilitate their injection; covalently linking the TGFβ3 to the microspheres to prevent its dispersal in the organism.


Disclosure:

M. Mathieu,
None;

E. Belamie,
None;

M. N. Labour,
None;

S. Vigier,
None;

C. Jorgensen,
None;

D. Noel,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/collagen-based-microspheres-delivering-tgf-%ce%b23-for-mesenchymal-stem-cell-differentiation-an-innovative-strategy-for-cartilage-engineering/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology